Cardiac β-Adrenoceptor Changes in Monocrotaline-Treated Rats: Differences Between Membrane Preparations From Whole Ventricles and Isolated Ventricular Cardiomyocytes-Reference-Cited by-同舟云学术

Cardiac β-Adrenoceptor Changes in Monocrotaline-Treated Rats: Differences Between Membrane Preparations From Whole Ventricles and Isolated Ventricular Cardiomyocytes

Published:2003-03 Issue:3 Volume:41 Page:333-342
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Leineweber Kirsten,Seyfarth Torsten,Abraham Getu,Gerbershagen Hans-Peter,Heinroth-Hoffmann Ingrid,Pönicke Klaus,Brodde Otto-Erich

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference48 articles.

1. Rat models of hypertension, cardiac hypertrophy and failure

2. Animal models of human cardiovascular disease, heart failure and hypertrophy

3. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of alamandine on monocrotaline-induced pulmonary hypertension in rats;IRAN J BASIC MED SCI;2024

2. Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function;Cells;2023-12-04

3. Increased Mitochondrial Calcium Fluxes in Hypertrophic Right Ventricular Cardiomyocytes from a Rat Model of Pulmonary Artery Hypertension;Life;2023-02-15

4. Protective effect of nicotinamide and l-arginine against monocrotaline-induced pulmonary hypertension in rats: gender dependence;Pharmacological Reports;2020-07-06

5. The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension;Frontiers in Cardiovascular Medicine;2018-12-17